Literature DB >> 17479775

Defibrinated bovine plasma inhibits retroviral transcription by blocking p52 activation of the NFkappaB element in the long terminal repeat.

Marianne J van den Heuvel1, Karen F Copeland, Elizabeth C Cates, Barbara J Jefferson, Robert M Jacobs.   

Abstract

Bovine leukemia virus (BLV) induces a persistent but latent infection in cattle. Viral latency is invoked by a protein known as plasma blocking factor (PBF) that is found in both bovine and human plasma. We report here on pathways that mediate latency in the presence of PBF. Reporter-gene constructs driven by the promoters of 6 retroviruses were used to measure the production of chloramphenicol acetyl transferase (CAT) in cell lines cultured with or without defibrinated bovine plasma. Plasma inhibited CAT production only in constructs containing an NFkappaB-binding element proximal to the initiation site (BLV, human immunodeficiency virus, and human T-cell leukemia virus). The promoters of Bovine immunodeficiency virus, Feline immunodeficiency virus, or Feline leukemia virus were not inhibited in the presence of bovine plasma. Using gel mobility shift assays, we demonstrated that activation of viral transcription upon stimulation with phorbol esters and ionomycin was mediated through the NFkappaB element and that this was abrogated in the presence of plasma. Furthermore, analysis of individual NFkappaB proteins in nuclear extracts of mononuclear cells or Jurkat cells showed that all 5 members of the NFkappaB family were upregulated in response to stimulation, but only p52 was significantly downregulated in the presence of bovine plasma. Thus, we infer that plasma effects are mediated through interference with either p52 translocation to the nucleus or p52 synthesis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17479775      PMCID: PMC1829189     

Source DB:  PubMed          Journal:  Can J Vet Res        ISSN: 0830-9000            Impact factor:   1.310


  40 in total

Review 1.  Missing pieces in the NF-kappaB puzzle.

Authors:  Sankar Ghosh; Michael Karin
Journal:  Cell       Date:  2002-04       Impact factor: 41.582

2.  Elevated levels of mRNA can account for the trans-activation of human immunodeficiency virus.

Authors:  B M Peterlin; P A Luciw; P J Barr; M D Walker
Journal:  Proc Natl Acad Sci U S A       Date:  1986-12       Impact factor: 11.205

3.  Upstream stimulatory factors binding to an E box motif in the R region of the bovine leukemia virus long terminal repeat stimulates viral gene expression.

Authors:  Claire Calomme; Thi Lien-Anh Nguyen; Yvan de Launoit; Veronique Kiermer; Louis Droogmans; Arsene Burny; Carine Van Lint
Journal:  J Biol Chem       Date:  2001-12-10       Impact factor: 5.157

4.  Bovine leukemia virus long terminal repeat: a cell type-specific promoter.

Authors:  D Derse; S J Caradonna; J W Casey
Journal:  Science       Date:  1985-01-18       Impact factor: 47.728

5.  Spontaneously proliferating lymphocytes from bovine leukaemia virus-infected, lymphocytotic cattle are not the virus-expressing lymphocytes, as these cells are delayed in G(0)/G(1) of the cell cycle and are spared from apoptosis.

Authors:  D M Stone; L K Norton; W C Davis
Journal:  J Gen Virol       Date:  2000-04       Impact factor: 3.891

6.  Involvement of intracellular Ca2+ in the regulation of bovine leukemia virus expression.

Authors:  A Bondzio; A Abraham-Podgornik; P Blankenstein; S Risse
Journal:  Biol Chem       Date:  2001-03       Impact factor: 3.915

7.  Transcriptional control of the bovine leukemia virus genome: role and characterization of a non-immunoglobulin plasma protein from bovine leukemia virus-infected cattle.

Authors:  P Gupta; S V Kashmiri; J F Ferrer
Journal:  J Virol       Date:  1984-04       Impact factor: 5.103

8.  Leukemogenesis by bovine leukemia virus: proviral DNA integration and lack of RNA expression of viral long terminal repeat and 3' proximate cellular sequences.

Authors:  R Kettmann; J Deschamps; Y Cleuter; D Couez; A Burny; G Marbaix
Journal:  Proc Natl Acad Sci U S A       Date:  1982-04       Impact factor: 11.205

9.  Adaptation of a sandwich enzyme-linked immunosorbent assay to determine the concentration of bovine leukemia virus p24 and optimal conditions for p24 expression in short-term cultures of peripheral blood mononuclear cells.

Authors:  M van den Heuvel; D Portetelle; B Jefferson; R M Jacobs
Journal:  J Virol Methods       Date:  2003-07       Impact factor: 2.014

10.  Location of cis-acting regulatory sequences in the human T-cell leukemia virus type I long terminal repeat.

Authors:  C A Rosen; J G Sodroski; W A Haseltine
Journal:  Proc Natl Acad Sci U S A       Date:  1985-10       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.